SGLT2 Inhibitors in Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Meta-Analysis. [PDF]
Tantush A +12 more
europepmc +1 more source
SAR-Guided Scaffold Innovation of Selective V<sub>2</sub>R Antagonists: Therapeutic Frontiers in ADPKD. [PDF]
Shi H, Li Y, Liang SH.
europepmc +1 more source
Efficacy and safety of tolvaptan in rapidly progressing autosomal dominant polycystic kidney disease: a single-center, prospective, single-arm study. [PDF]
Zhou L, Li W.
europepmc +1 more source
ESKD from primary glomerulonephritis: Incidence and post KRT survival: A national cohort study in the UK. [PDF]
A Roberts S +8 more
europepmc +1 more source
Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease. [PDF]
Betkar S +4 more
europepmc +1 more source
Multifocal Uremic Tumoral Calcinosis From Prolonged Hyperparathyroidism in Autosomal Dominant Polycystic Kidney Disease. [PDF]
Harris MJ, Pedraza Cruz P, Junejo S.
europepmc +1 more source
Response to the Letter to the Editor Entitled "The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD". [PDF]
Wang J, Lee SY, Chao CT.
europepmc +1 more source
Retroperitoneoscopic Nephrectomy at the Time of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: Safety, Efficacy, Feasibility, and Cosmetic Outcomes. [PDF]
Ohyama T +4 more
europepmc +1 more source
The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD. [PDF]
Paolisi M +8 more
europepmc +1 more source
CART for ascites accumulation and dialysis difficulty after hepatic cyst fenestration and bilateral nephrectomy in ADPKD: a case report. [PDF]
Sawada S +12 more
europepmc +1 more source

